William J Newell Sutro Biopharma, Inc. (STRO) insider trading activity

William J Newell is CEO of SUTRO BIOPHARMA, INC.. Currently has a direct ownership of 220,203 shares of STRO, which is worth approximately $929,256. The most recent transaction as insider was on Mar 05, 2024, when has been sold 6,690 shares (Common Stock) at a price of $4.54 per share, resulting in proceeds of $30,372. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 220K

17.05% 3M change

33.61% 12M change

Total Value Held $929,256

WILLIAM J NEWELL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 05 2024	SELL Payment of exercise price or tax liability	$30,372 $4.54 p/Share	6,690 Reduced 2.95%	220,203 Common Stock
Mar 05 2024	BUY Exercise of conversion of derivative security	-	18,750 Added 7.63%	226,893 Common Stock
Mar 04 2024	SELL Payment of exercise price or tax liability	$53,192 $4.79 p/Share	11,105 Reduced 5.07%	208,143 Common Stock
Mar 04 2024	BUY Exercise of conversion of derivative security	-	31,125 Added 12.43%	219,248 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$42,367 $4.95 p/Share	8,559 Reduced 4.35%	188,123 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	-	23,750 Added 10.77%	196,682 Common Stock
Jan 29 2024	SELL Payment of exercise price or tax liability	$28,113 $4.99 p/Share	5,634 Reduced 3.16%	172,932 Common Stock

Jan 29 2024	BUY Exercise of conversion of derivative security	-	13,750 Added 7.15%	178,566 Common Stock
Mar 03 2023	SELL Payment of exercise price or tax liability	$99,854 $5.79 p/Share	17,246 Reduced 9.47%	164,816 Common Stock
Mar 03 2023	BUY Exercise of conversion of derivative security	-	49,875 Added 21.5%	182,062 Common Stock
Jan 27 2023	SELL Payment of exercise price or tax liability	$42,000 $7.5 p/Share	5,600 Reduced 4.06%	132,187 Common Stock
Jan 27 2023	BUY Exercise of conversion of derivative security	-	13,750 Added 9.07%	137,787 Common Stock
Mar 05 2022	SELL Payment of exercise price or tax liability	$52,966 $8.17 p/Share	6,483 Reduced 5.41%	113,460 Common Stock
Mar 05 2022	BUY Exercise of conversion of derivative security	-	18,750 Added 13.52%	119,943 Common Stock
Jan 29 2022	SELL Payment of exercise price or tax liability	$54,838 $10.39 p/Share	5,278 Reduced 4.96%	101,193 Common Stock
Jan 29 2022	BUY Exercise of conversion of derivative security	-	13,750 Added 11.44%	106,471 Common Stock
Sep 24 2021	SELL Payment of exercise price or tax liability	$254,201 $19.23 p/Share	13,219 Reduced 12.48%	92,721 Common Stock
Sep 24 2021	BUY Exercise of conversion of derivative security	-	25,253 Added 19.25%	105,940 Common Stock
Jul 01 2021	SELL Bona fide gift	-	104,662 Reduced 56.47%	80,687 Common Stock
Jan 29 2021	SELL Payment of exercise price or tax liability	$156,401 $22.15 p/Share	7,061 Reduced 3.67%	185,349 Common Stock
Jan 29 2021	BUY Exercise of conversion of derivative security	-	13,750 Added 6.67%	192,410 Common Stock

Also insider at

PCVX

Vaxcyte, Inc. Healthcare

Director

WJN

William J Newell

CEO

Foster City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STRO shares.

Notify only if

Value

Insider Trading

Get notified when an Sutro Biopharma, Inc. insider buys or sells STRO shares.

Notify only if

Operation

Value

Type

News

Receive news related to SUTRO BIOPHARMA, INC.

Track Activities on STRO

Account